SCPHARMACEUTICALS INC.

scPharmaceuticals Inc. Announces Appointment of Rachael Nokes as Chief Financial Officer

19 12 2022 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event

14 12 2022 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces Pricing of $50 Million Public Offering

22 11 2022 08:01:42 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock

21 11 2022 16:01:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update

09 11 2022 16:05:03 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Participate in the Jefferies London Healthcare Conference

02 11 2022 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 9, 2022

26 10 2022 08:00:02 提供 Nasdaq GlobeNewswire

UPDATE - scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure

10 10 2022 09:41:38 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces $100 Million Debt Financing Agreement with Oaktree

10 10 2022 08:05:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure

10 10 2022 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting

30 9 2022 08:00:00 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

01 9 2022 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

09 8 2022 07:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion

13 7 2022 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure

12 7 2022 08:00:02 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. to Host FUROSCIX® (furosemide) 80mg/10mL for Subcutaneous Administration Commercial Day: An Investigational Treatment for Heart Failure Patients

30 6 2022 08:00:02 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Abstracts Accepted for Presentation at the American Association of Heart Failure Nurses 18th Annual Meeting

07 6 2022 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Healthcare Conference

24 5 2022 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

17 5 2022 08:00:01 提供 Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

16 5 2022 07:10:00 提供 Nasdaq GlobeNewswire